Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate for long-term mechanical ventilation sedation in ICU (Phase II, single-arm, observational)
CTR20231807Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remimazolam in sedation, sponsored by Hengrui Therapeutics. Started Jun 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
sedation
Beyond the preview
Go deeper on CTR20231807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231807.